PSA announce deadline for MMR RPL processing guarantee

18 February 2025

 

The Pharmaceutical Society of Australia (PSA) is encouraging pharmacists seeking Recognition of Prior Learning (RPL) for the new Medication Management Review (MMR) Credential to ensure all evidence is submitted by 22 April 2025 to guarantee processing before interim funding arrangements end on 30 June.

 

From 1 July 2025, pharmacists who have not obtained a new credential will be unable to claim fees for MMR services, as current Medication Review Numbers (MRNs) will become invalid.

 

PSA guarantees that pharmacists who submit a complete MMR RPL application before 22 April will have their RPL processed and new credential issued before 1 July. Submission made after this date will still be processed however may not be completed before 1 July.

 

As part of PSA’s ongoing support for consultant pharmacists, PSA also continue to provide complimentary MMR RPL for professional plus members.

 

PSA National President Associate Professor Fei Sim FPS said the guarantee gives pharmacists certainty about their ability to continue providing MMR services uninterrupted.

 

“The temporary extension of MRNs meant that pharmacists had more time to transition to new credentials, minimising disruption to patient services and allowing the existing workforce to continue providing MMR services,” Associate Professor Sim said.

 

“As we now approach the end of this extension, our team is preparing for an influx of applications.

 

“To ensure that critical MMR services are not interrupted, PSA is guaranteeing that all RPL applications submitted before 22 April will be processed before 1 July.

 

“I strongly encourage pharmacists who have not yet enrolled in the RPL course and submitted the required evidence to do so as soon as possible, ensuring that your services are not interrupted on 1 July,” Associate Professor Sim concluded.

 

PSA Consultant Pharmacist Community of Specialty Interest Chair Deborah Hawthorne FPS CredPharm (MMR) also encouraged pharmacists to connect with the CSI for support.

 

“As the temporary extension of our MRNs comes to an end, now is time to gather and submit evidence for your RPL,” Ms Hawthorne said.

 

“Our Consultant Pharmacists CSI Facebook group is a valuable resource for members undertaking RPL, particularly when it comes to the peer review process. I encourage PSA members to join our community and reach out to peers for support as we near 1 July.”

 

PSA has provided pharmacists detailed information and a step-by-step guide to submitting RPL evidence on a dedicated webpage, available here. PSA’s friendly credentialing team is also available to assist learners via credentialing@psa.org.au

​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au